These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27375613)

  • 1. HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.
    Evans C; Humphrey JH; Ntozini R; Prendergast AJ
    Front Immunol; 2016; 7():190. PubMed ID: 27375613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
    Koyanagi A; Humphrey JH; Ntozini R; Nathoo K; Moulton LH; Iliff P; Mutasa K; Ruff A; Ward B;
    Pediatr Infect Dis J; 2011 Jan; 30(1):45-51. PubMed ID: 21173675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children.
    Slogrove AL; Goetghebuer T; Cotton MF; Singer J; Bettinger JA
    Front Immunol; 2016; 7():164. PubMed ID: 27199989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Slogrove AL; Esser MM; Cotton MF; Speert DP; Kollmann TR; Singer J; Bettinger JA
    Pediatr Infect Dis J; 2017 Feb; 36(2):e38-e44. PubMed ID: 28081048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era.
    Evans C; Chasekwa B; Ntozini R; Humphrey JH; Prendergast AJ
    AIDS; 2016 Sep; 30(15):2323-8. PubMed ID: 27428746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods.
    Duri K; Gumbo FZ; Munjoma PT; Chandiwana P; Mhandire K; Ziruma A; Macpherson A; Rusakaniko S; Gomo E; Misselwitz B; Mazengera LR;
    BMC Infect Dis; 2020 Oct; 20(1):725. PubMed ID: 33008316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
    Desmonde S; Goetghebuer T; Thorne C; Leroy V
    Curr Opin HIV AIDS; 2016 Sep; 11(5):465-476. PubMed ID: 27716731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Child Growth According to Maternal and Child HIV Status in Zimbabwe.
    Omoni AO; Ntozini R; Evans C; Prendergast AJ; Moulton LH; Christian PS; Humphrey JH
    Pediatr Infect Dis J; 2017 Sep; 36(9):869-876. PubMed ID: 28198792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants.
    Ruck C; Reikie BA; Marchant A; Kollmann TR; Kakkar F
    Front Immunol; 2016; 7():310. PubMed ID: 27594857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, cytomegalovirus and the growth hormone axis in HIV-exposed uninfected Zimbabwean infants.
    Evans C; Chasekwa B; Rukobo S; Govha M; Mutasa K; Ntozini R; Humphrey JH; Prendergast AJ
    AIDS; 2020 Nov; 34(14):2045-2050. PubMed ID: 32773472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-exposed-uninfected infants have increased inflammation and monocyte activation.
    Dirajlal-Fargo S; Mussi-Pinhata MM; Weinberg A; Yu Q; Cohen R; Harris DR; Bowman E; Gabriel J; Kulkarni M; Funderburg N; Chakhtoura N; McComsey GA;
    AIDS; 2019 Apr; 33(5):845-853. PubMed ID: 30649056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Risk of Group B
    Dauby N; Chamekh M; Melin P; Slogrove AL; Goetghebuer T
    Front Immunol; 2016; 7():505. PubMed ID: 27899925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Perinatal HIV Infection Is Associated With Increased Infectious Morbidity in HIV-exposed Uninfected Infants.
    Powis KM; Slogrove AL; Okorafor I; Millen L; Posada R; Childs J; Abrams EJ; Sperling RS; Jao J
    Pediatr Infect Dis J; 2019 May; 38(5):500-502. PubMed ID: 30461574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.
    Brennan AT; Bonawitz R; Gill CJ; Thea DM; Kleinman M; Useem J; Garrison L; Ceccarelli R; Udokwu C; Long L; Fox MP
    AIDS; 2016 Sep; 30(15):2351-60. PubMed ID: 27456985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.
    Anderson K; Kalk E; Madlala HP; Nyemba DC; Jacob N; Slogrove A; Smith M; Kroon M; Harrison MC; Eley BS; Boulle A; Myer L; Davies MA
    AIDS; 2021 May; 35(6):921-931. PubMed ID: 33821822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort.
    Lohman-Payne B; Gabriel B; Park S; Wamalwa D; Maleche-Obimbo E; Farquhar C; Bosire RK; John-Stewart G
    Clin Transl Med; 2018 Sep; 7(1):26. PubMed ID: 30198049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants.
    Evans C; Chasekwa B; Rukobo S; Govha M; Mutasa K; Ntozini R; Humphrey JH; Prendergast AJ
    J Infect Dis; 2017 Mar; 215(5):698-702. PubMed ID: 28011912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of exposure to HIV in neonates at a referral hospital in South Africa.
    Mellqvist H; Saggers RT; Elfvin A; Hentz E; Ballot DE
    BMC Pediatr; 2021 Nov; 21(1):485. PubMed ID: 34727920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Trajectories of HIV Exposed and HIV Unexposed Infants. A Prospective Study in Gweru, Zimbabwe.
    Mabaya L; Matarira HT; Tanyanyiwa DM; Musarurwa C; Mukwembi J
    Glob Pediatr Health; 2021; 8():2333794X21990338. PubMed ID: 33614842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol.
    Shivakoti R; Slogrove AL; Laughton B; Shafiq M; Schoeman E; Glashoff RH; Leu CS; Wang S; Bode L; Aldrovandi G; Kuhn L
    BMJ Open; 2022 Dec; 12(12):e069116. PubMed ID: 36585139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.